hims & hers fda warning letter compounded semaglutide 2025 From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hers, an online health and wellness platform, announced its intention to sell oral semaglutide, a glucagon-like peptide-1 ( New project announcement: HHS‑OIG is

You can continue your treatment with us while benefiting from enhanced support and a more personalized, medically supervised approach

Compounded GLP-1 medications are typically much cheaper than their branded counterparts

Bottom Line GLP-1 agonists have a place in medicine as treatment for Type 2 diabetes and obesity, offering benefits in blood sugar control and weight loss

Every unit we ship carries full documentation, batch records, and verified purity certifications

Our intake appointments went smoothly, though one tester ran into some difficulty uploading an ID

How retatrutide works differently from other weight loss peptides Understanding why retatrutide affects body composition the way it does requires looking at its unique mechanism